Mometasone furoate/olopatadine hydrochloride
Mometasone furoate/olopatadine hydrochloride was ranked 505th of 1,792 medicines by items in April 2026, with 9,489 items, up 78.7% on a year earlier.
Dispensed in April 2026
Rolling 12 months
Net ingredient cost · April 2026
Figure 1. Mometasone furoate/olopatadine hydrochloride: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
At a glance
- Therapeutic class Drugs acting on the nose
- Presentations 1 shown
- Average cost / item £14.58
- Year on year Up 78.7% on a year earlier
Top presentations, April 2026
The individual products dispensed under Mometasone furoate/olopatadine hydrochloride this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray | 1202010Z0BBAAAA | 9,489 | £138,342 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Mometasone furoate/olopatadine hydrochloride is dispensed
The regions and dispensing practices with the highest Mometasone furoate/olopatadine hydrochloride volumes.
Top regions
Top dispensing practices
- The Atherstone Surgery 1,014
- Wickham Surgery 638
- Garstang Medical Practice 590
- Probus Surgery 474
- Clays Practice 361
- Modality Partnership (awc) 329
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Mometasone furoate/olopatadine hydrochloride with
Other medicines in the same BNF section, by prescribing volume.